174 related articles for article (PubMed ID: 31661471)
1. Relationship Between Diabetes Mellitus and Cirrhosis Risk in Chronic Hepatitis B Patients in Wuhan, China.
Xu C; Chen J; Zhang PA
Med Sci Monit; 2019 Oct; 25():8112-8119. PubMed ID: 31661471
[TBL] [Abstract][Full Text] [Related]
2. Diabetes Mellitus is a Risk Factor for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection in China.
Li X; Xu H; Gao P
Med Sci Monit; 2018 Sep; 24():6729-6734. PubMed ID: 30245503
[TBL] [Abstract][Full Text] [Related]
3. Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma: a cross-sectional case-control study from Chinese patients with HBV infection.
Gao C; Fang L; Zhao HC; Li JT; Yao SK
Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):385-93. PubMed ID: 23924496
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients.
Li X; Gao Y; Xu H; Hou J; Gao P
Sci Rep; 2017 Aug; 7(1):9087. PubMed ID: 28831144
[TBL] [Abstract][Full Text] [Related]
5. Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus.
Zhang H; Gao C; Fang L; Yao SK
World J Gastroenterol; 2013 Apr; 19(15):2395-403. PubMed ID: 23613635
[TBL] [Abstract][Full Text] [Related]
6. Identifying patients with chronic hepatitis B at high risk of type 2 diabetes mellitus: a cross-sectional study with pair-matched controls.
Shen Y; Zhang J; Cai H; Shao JG; Zhang YY; Liu YM; Qin G; Qin Y
BMC Gastroenterol; 2015 Mar; 15():32. PubMed ID: 25887997
[TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes and hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.
Li Q; Li WW; Yang X; Fan WB; Yu JH; Xie SS; Liu L; Ma LX; Chen SJ; Kato N
Int J Cancer; 2012 Sep; 131(5):1197-202. PubMed ID: 22052244
[TBL] [Abstract][Full Text] [Related]
8. Diabetes poses a higher risk of hepatocellular carcinoma and mortality in patients with chronic hepatitis B: A population-based cohort study.
Shyu YC; Huang TS; Chien CH; Yeh CT; Lin CL; Chien RN
J Viral Hepat; 2019 Jun; 26(6):718-726. PubMed ID: 30739359
[TBL] [Abstract][Full Text] [Related]
9. Chronic hepatitis B infection and diabetes mellitus: a double liver trouble?
Abu Baker F; Davidov Y; Israel A; Green I; Taher R; Ben Ari Z; Abu Mouch S
Minerva Med; 2023 Oct; 114(5):658-666. PubMed ID: 36912857
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection.
Chayanupatkul M; Omino R; Mittal S; Kramer JR; Richardson P; Thrift AP; El-Serag HB; Kanwal F
J Hepatol; 2017 Feb; 66(2):355-362. PubMed ID: 27693539
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus increases the risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis C patients in China.
Li X; Xu H; Gao Y; Pan M; Wang L; Gao P
Medicine (Baltimore); 2017 Mar; 96(13):e6508. PubMed ID: 28353605
[TBL] [Abstract][Full Text] [Related]
12. ABO blood group and the risk of hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.
Li Q; Yu CH; Yu JH; Liu L; Xie SS; Li WW; Yang X; Fan WB; Gai ZT; Chen SJ; Kato N
PLoS One; 2012; 7(1):e29928. PubMed ID: 22235351
[TBL] [Abstract][Full Text] [Related]
13. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study.
Kim G; Jang SY; Nam CM; Kang ES
J Hepatol; 2018 Mar; 68(3):476-484. PubMed ID: 29107150
[TBL] [Abstract][Full Text] [Related]
14. Stratification of hepatocellular carcinoma risk through modified FIB-4 index in chronic hepatitis B patients on entecavir therapy.
Wang HW; Lai HC; Hu TH; Su WP; Lu SN; Lin CH; Hung CH; Chuang PH; Wang JH; Lee MH; Chen CH; Peng CY
J Gastroenterol Hepatol; 2019 Feb; 34(2):442-449. PubMed ID: 29968933
[TBL] [Abstract][Full Text] [Related]
15. [Study on the risk of hepatitis B-related cirrhosis combined with type 2 diabetes mellitus for the occurrence of primary hepatocellular carcinoma].
Zhang LL; Li YF; Zhang C; Wu XF; Ma Y; Li L
Zhonghua Gan Zang Bing Za Zhi; 2019 Oct; 27(10):788-792. PubMed ID: 31734994
[No Abstract] [Full Text] [Related]
16. [Analysis of the risk factors of hepatocellular carcinoma in cirrhotic patients with chronic hepatitis B].
Zhang Y; Peng L; Cao Y; Zeng Z; Wu Y; Shi H; Chen S; Guo J
Zhonghua Gan Zang Bing Za Zhi; 2015 Jul; 23(7):512-6. PubMed ID: 26398842
[TBL] [Abstract][Full Text] [Related]
17. Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.
Jeon MY; Lee HW; Kim SU; Heo JY; Han S; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
Hepatol Int; 2017 May; 11(3):268-276. PubMed ID: 28224351
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of acute hepatitis E super-infections on chronic hepatitis B.
Chen C; Zhang SY; Zhang DD; Li XY; Zhang YL; Li WX; Yan JJ; Wang M; Xun JN; Lu C; Ling Y; Huang YX; Chen L
World J Gastroenterol; 2016 Dec; 22(47):10388-10397. PubMed ID: 28058019
[TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus and hepatocellular carcinoma: comparison of Chinese patients with and without HBV-related cirrhosis.
Gao C; Zhao HC; Li JT; Yao SK
World J Gastroenterol; 2010 Sep; 16(35):4467-75. PubMed ID: 20845516
[TBL] [Abstract][Full Text] [Related]
20. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
Hu HH; Liu J; Lin YL; Luo WS; Chu YJ; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; You SL; Yang HI; Chen CJ;
Gut; 2016 Sep; 65(9):1514-21. PubMed ID: 26642861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]